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Abstract
Background: Genital warts, which are caused by infection with human papillomavirus (HPV), are one of the most
common sexually transmitted diseases in Europe. Although genital warts are commonly perceived as a non-serious
condition, treatment is often long, of varying effectiveness and the recurrence rate is high. Very few studies have
been performed on the personal consequences of genital warts. The aim of this qualitative study, set in Denmark,
was to examine the ways in which genital warts may affect patients’ quality of life.
Methods: To obtain an in-depth understanding of patients’ perceptions of genital warts, we used qualitative focus-
group interviews with five men and five women aged between 18 and 30 years who had genital warts. The
interview guide was based on a literature review that identified important issues and questions. The data were
analysed using a medical anthropological approach.
Results: Patients’ experiences were related to cultural conceptions of venereal diseases and the respective
identities and sexuality of the sexes. The disease had negative psychological and social effects both for men and
for women and it affected their sex and love lives, in particular. The psychological burden of the disease was
increased by the uncertain timeline and the varying effectiveness of treatment. We identified a need for more
patient information about the disease and its psycho-sexual aspects.
Conclusions: The men and women participating in this study considered their quality of life to be significantly
lowered because of genital warts. The experiences described by the participants give insights that may be valuable
in treatment and counselling.
The quadrivalent HPV vaccine that has now been added to the childhood vaccination programme for girls in Den-
mark for the prevention of cervical cancer can also prevent 90% of cases of genital warts. Our results suggest that
HPV vaccination could considerably reduce the largely unacknowledged psychological and social burden asso-
ciated with genital warts, in men as well as women.
Background
It was recently reported that 10.6% of women aged 18-
45 years in northern Europe have had genital warts
(GWs) and that the incidence of GWs among young
women is rising [1]. In the United Kingdom, for exam-
ple, GWs are now the most prevalent venereal disease
and the number of reported cases has increased by
almost ten times within the past 30 years [2]. The treat-
ment of GWs is often long and of varying efficacy [3].
In Denmark, a country with 5 million inhabitants, 17%
of women aged 20-29 years have had GWs [4]. The
Danish National Health Board has estimated that annual
expenditure on treatment of GWs is approximately 3.9
million euros [5].
GWs are caused by infection with certain types of
human papillomavirus (HPV). More than 100 types of
HPV exist, of which between 30 and 40 are associated
with the mucosa and skin of the anogenital area [6-8].
Approximately 90% of cases of GWs are due to infection
by HPV types 6 and 11. The use of condoms reduces
but does not eliminate the risk of HPV infection [9].
Although most HPV-related genital lesions resolve
spontaneously within 1-2 years, there is no specific
treatment for persistent HPV infection [10]. Most
patients require more than one course of treatment for
visible GWs, and the choice of therapy depends on the
location, number and size of the lesions. Management
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toxin, 5% imiquimod cream or 5% 5-fluorouracil cream,
or physician application of 20% Podophyllin resin,
cryotherapy, surgical excision or carbon-dioxide laser.
All treatments are associated with a degree of discom-
fort for the patient and subsequent local reactions such
as burning, irritation of the mucosal membranes and
ulceration. The efficacy of the different treatments varies
between 20% and 60% and the rate of recurrence of
GWs is high [11-15].
Public interest in HPV vaccination has so far centred
on the possibility of preventing cervical cancer. Several
European countries, Australia and the USA have intro-
duced HPV vaccination programmes for young girls to
prevent cervical cancer. In Denmark, for example, HPV
vaccination of 12-year old girls was introduced to the
children’s vaccination programme in the autumn of
2008 [5,16]. However, the quadrivalent HPV vaccine
(Gardasil®) protects not only against HPV types 16 and
18, which cause approximately 70% of cervical cancers,
but also against types 6 and 11 and thus has the poten-
tial to prevent 90% of GWs [17,18].
GWs are often perceived as benign and non-serious
infections, and there have been few studies on the qual-
ity of life of patients with GWs; the majority of studies
on HPV-related diseases concern women’s experiences
with cervical dysplasia and cervical cancer [19-31]. Qual-
ity of life is defined here as the psychological, social and
physical well-being of the patient. The sparse literature
identified during the present study [3,14,15,32-45] indi-
cated that patients with GWs suffer anxiety about the
effect of the disease on their love life and sexual
[3,32,36-38,40,43,44] and social relationships [32,36], the
stigma of having contracted a venereal disease
[34,35,38,39,43,45], the uncertain treatment success and
time to cure [3,14,32,34-36,40,44] and transmission of
the disease to others [3,32,36,40,37]. Several studies
report that the negative psychological effects of the dis-
ease are the most difficult [14,35,36,38,43,45]. They
include feelings of anger, fear caused by the relationship
of HPV to cervical cancer, guilt, depression, self-loathing
and worries about the future [3,14,32,34-40,42-45].
Finally, the literature points to a huge need for more
information about the disease and an improved doctor-
patient communication [3,14,15,33,35,36,38,41,43,45]. Of
the 17 relevant articles identified [3,14,15,32-45], only
two were based on qualitative studies [3,32]. The objec-
tive of this qualitative study, the first of its kind in a
Danish context, was to gain an in-depth understanding
of the ways in which GWs may affect patients’ quality of
life.
A qualitative approach is the most appropriate to
examine patients’ perceptions of a disease in a given
socio-cultural context. The strength of the qualitative
approach lies in its ability to explain patterns of mean-
ing and answer questions such as, ‘what?’, ‘how?’ and
‘why?’,r a t h e rt h a n‘how many?’ or ‘how often?’.T h e
results can be generalised analytically in the sense that
we gain knowledge about the qualities of a phenomenon
regardless of the frequency of its occurrence [46].
The medical-anthropological basis for this study was
that a person’s perception of a disease influences his/her
personal experience of it. Kleinman has proposed a dis-
tinction between the terms disease, referring to the bio-
medical condition from the practitioner’sp o i n to fv i e w ,
and illness, referring to the patients’ perception of the
condition and coping with it [47,48]. According to the
illness paradigm, patients create cognitive models of
their illness which constitute five core dimensions: iden-
tity, cause, control, timeline and consequences (Figure
1). The perception of each of these dimensions influ-
ences how patients cope with their illness. For instance,
the degree of anxiety caused by an illness is greater if
the perceived consequences are serious, if the patients
feel they have no control over the illness, if the treat-
ment effectiveness is poor or if the time to cure is long
and uncertain [34]. In this study, we aimed to examine
patients’ cognitive models of genital warts.
Methods
The present study was based on qualitative focus group
interviews with both men and women. This methodol-
ogy, focus groups, was chosen to create a confidential
setting in which people could openly and anonymously
discuss their experiences of the disease. The aim was to
gain an insight into as broad a range of perspectives on
t h ed i s e a s ea sp o s s i b l e .A tt h es a m et i m e ,u s i n gf o c u s
groups allowed us to observe the dynamic and social
construction of GWs. The groups were small and sin-
gle-sexed to help the participants to feel more comforta-
ble talking about the subject. We recruited participants
aged between 18 and 30 years because the prevalence of
GWs is highest in this age group, and also because
being of a similar age usually helps to encourage honest
and open group discussions [49,50].
The 10 participants (five women and five men) were
recruited from the venereal diseases clinic at Bispeb-
jerg Hospital in Copenhagen, Denmark, which has
approximately 8000 consultations for GWs per year.
Participants were eligible if they were aged between 18
a n d3 0y e a r so l d ,h a ds u f f e r e df r o mG W sf o ra tl e a s t
three months, were seeking treatment at the time of
inclusion, and did not have any serious co-morbidity
or any other sexually transmitted disease. Patients who
fulfilled the inclusion criteria were informed orally
about the study by the consulting physician, who also
gave them a study information sheet. Patients wishing
to participate then contacted GLM, who acted as an
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informed consent. No personal information about the
participants was passed on from the venereal diseases
clinic to the authors or other people involved in the
study. The participants’ anonymity was ensured
throughout the study that did not require ethics com-
mittee approval in Denmark. All the participants were
ethnically Danish.
The focus-group discussions were held after working
hours in a small library at the Venereal Diseases Clinic,
because this was a neutral but familiar environment.
The focus groups were moderated by GLM with the
assistance of an experienced anthropology student. The
purpose and design of the focus group was explained
before the interviews started. A semi- and funnel-struc-
tured interview guide (Table 1) was used to moderate
the focus-group discussions. Following the cognitive ill-
ness model, the interview guide began with questions to
the participants’ perceptions of genital warts: the per-
ceived causes, means of controlling and time-line of
GW. Subsequently, more focus was brought on the per-
sonal consequences of having GW, including the effects
on patients’ identity. With this aim, the interview guide
covered topics and questions that were identified and
formulated on the basis of a literature search using
PubMed, Embase, CINAHL and Psycinfo. The questions
were open-ended to capture as many perspectives as
possible, including any that had not been envisaged by
pre-interview hypotheses [49].
The focus-group discussions were transcribed verba-
tim and analysed using NVivo, a software programme
for analysing qualitative data (QSR International).
A social constructivist approach to the relationship
between language and the social construction of mean-
ing was used to analyse the data [50]. This approach is
used to analyse a diversity of statements such that clus-
ters of meaning around specific subject matter are gen-
erated. It involves an analysis of the terminology used to
speak about the subject and the ways in which it is
related to other issues. Firstly, the data were coded into
the topics that were brought up during the discussions.
Secondly, the most important themes within each topic
were identified. Finally, the frequency of and connec-
tions between topics and themes were analysed. This
generated a pattern of the relative meaning that the dif-
ferent topics and themes had for the participants, i.e.
the most significant ways their quality of life had been
affected by having GWs. All methodological and analyti-
cal steps were discussed with an anthropologist who was
not involved in the project.
Figure 1 Application of the cognitive model of illness (comprising five core dimensions) to the case of genital warts. Modified from
[34].
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T h ea v e r a g ea g eo ft h em e na n dw o m e ni nt h i ss t u d y
was 25.8 years and 24.4 years, respectively. The partici-
pants had had their present case of GW between 3-38
m o n t h sa tt h et i m eo ft h ef o c u sg r o u p s( T a b l e2 ) .T h i s
implies an average duration of 11 months. For seven
participants this was their first case of GW, while three
participants had an earlier (first) case of GW.
The participants were extremely frank during the focus
groups and several said that they had been glad to be able
to speak openly (for many, for the first time) with like-
minded people about their illness. Many participants said
they had volunteered because they wanted to participate
in the generation of knowledge about GWs and its perso-
nal consequences because they felt that the disease was
ignored, compared with other venereal diseases.
The quotes cited below were selected because they
illustrate some of the participants’ most important
experiences with GWs.
Illness perception: the cognitive model of genital warts
The participants regarded GWs as a stigmatising vener-
eal disease. This was expressed as shame and feelings of
being impure and repulsive. At the time of diagnosis,
most participants did not know that the virus can be
carried for some time before the GWs develop. Uncer-
tainties about the source of the infection often led to
worries about infidelity within the patients’ relationships.
The causal explanation of the illness was closely asso-
ciated with the idea that “somebody had done some-
thing wrong”.
The participants’ views on having GWs had changed
since the time of diagnosis. The majority did not know
Table 1 Interview guide
Interview
stage
Aim Question
Opening Presentation of participants What is your first name, age and how long have you been suffering from GWs?
Introductory
question
The participants’ reaction to the
diagnosis of GWs
1. How did you react when you heard that you had GWs?
Transitional
question
Perception of illness 2. What are your views on this disease (in comparison to other STDs, for instance)?
Cues: Cause, consequences, treatment options, time to cure and knowledge about HPV
Key questions The effect of GWs on their
quality of life
3. How has your lives been affected by having GWs?
a. Physical effects
b. The course of treatment
Cues: Pain, embarrassment, worries about treatment effectiveness and duration of treatment,
information and knowledge, doctor-patient communication, practical aspects
c. Effects on work and studies
Cues: Concerns about stigma, effect on ability to work or study, sick leave, contagion, social
avoidance
d. Social relations
Cues: Concerns about stigma, contagion, avoidance, social isolation
e. Love life
Cues: worries about present or future partners, infidelity, contagion, conflicts about infidelity or
disrupted sex life, fear of rejection and condemnation/disapproval
f. Sex life
Cues: Desire/lust, initiative, pleasure, spontaneity, avoidance, low self-esteem, negative body-
perception, fear of rejection, lack of sexual ability
g. Psychological effects
Cues: Guilt, shame, anger, worries about the future, depression, fear, negative self-perception,
identity, disease phobia
4. Has your quality of life changed since you were first diagnosed with GWs, and if yes, how?
Closing
questions
5. In conclusion, I would like each of you to tell me which of the areas that we have discussed
has been most affected by having GWs?
6. Is there anything you think we ought to have discussed but did not?
GWs, genital warts
Table 2 Focus group participants
Women Men
Age
(years)
Duration of present
case of GW (months)
Age
(years)
Duration of present
case of GW (months)
23 18 22 8 (84)*
24 4 30 3 (10)*
21 8 28 12
25 38 26 8
29 3 (24)* 23 8
*Parentheses referring to number of months since clearing of a first case of
case of GW, if any.
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optimistic about it being cured. Pessimism had gradually
set in as it became clear that treatment can be compli-
cated. The long and uncertain timeline as well as the
psycho-sexual consequences of the disease had taken
the participants by surprise and this had increased the
burden associated with GWs over time.
Ij u s tw e n t“s**t” but then I thought “well, it’ll soon
pass. I’ll just get a pill or something [she laughed].
But it wasn’t exactly like that. Now, I’ve changed my
perception pretty much. I’m really sick of it now.[ 2 3 -
year-old woman]
A few participants regarded GWs as a very serious
condition because they thought that GWs increased the
risk of developing cervical cancer. The majority, how-
ever, considered that GWs had mainly important psy-
cho-sexual effects on their quality of life.
The effect of genital warts on the patients’ love and sex
lives
The majority of participants indicated that it was their
sex and love life that had suffered most from having
GWs. Their libido was low and their sexual initiative
was reduced, and pleasure and spontaneity was often
lost during intercourse because of awareness of the
warts, fear of transmitting the disease or repulsing the
partner, negative self-perception and soreness due to
treatment. This affected steady relationships and for
those who were single it affected their ambition to seek
a new partner.
It [the GW] has definitely had a huge impact on my
sex life. It’s a barrier for meeting new girls. ‘Cause I
stand there thinking “Wow, she’sn i c e .I ’d like to take
her home”. But then, I don’tw a n tt oa p p r o a c hh e r
‘cause... I’m simply not up to explaining it. To me, it
has meant that I don’t really feel like going out and
looking for a new steady partner. That also totally
destroys your self-confidence, I mean, that you actu-
ally lose the desire to meet girls. [26-year-old man]
The participants described themselves as ‘impure,
repulsive and sexually unattractive’ and seriously ques-
tioned how others might find them attractive when they
did not even like themselves. Problems often arose in
existing relationships because of worries about the
source of the infection or a lack of sexual desire. Men,
in particular, often felt a pressure for sexual affirmation.
I think they [the GWs] affect you a lot, especially
when you kind of lose the desire for sex. I mean, it’s
not that you don’t think your girlfriend’s attractive or
anything... It’s like, it affects you psychologically and
you say: “No, I don’t think so. I don’t really care that
much for myself when I’m like this”. This resulted in
my girlfriend feeling that I didn’tf i n dh e rs e x yo r
beautiful, and just saying that she is wasn’te n o u g h
all of a sudden. And you can’t really do much more,
‘cause if you don’t feel like having sex, well, you just
don’t feel like it, damn it! [...] One of the most tedious
aspects of being treated with cryotherapy is that
nothing bloody works until the ulcers heal again -
and then you have to almost train it again after-
wards. It’s also really stressful in that when it finally
works again, you feel that you have to perform
because the tool has been out of order for a while. At
least, until my girlfriend and I talked about it, I felt
that she had these expectations: “Well, are you able
today?” And if you’re able, you sort of have to, ‘cause:
“Jeez, there’s only four days until your next treatment
so we better make use of the time”. I felt like there
was this pressure. [22-year old man]
The psychological effects of having genital warts
The psychological, social and sexual effects of having
GWs are all interrelated. Some participants had feelings
of guilt or anger because they had not protected them-
selves and others more carefully. Some men were
annoyed that they had put off seeking treatment for too
long. All participants had developed lower self esteem
and a negative body-perception as a result of the dis-
ease.
Sometimes, when you think about it or you notice
them [the GWs], you just become so discouraged and
sad because...you can’t do anything about it. I mean,
you just have to wait and there’s nothing you can do
yourself, is there? And then I get this feeling that I
simply can’t relate to my own body or even look at it.
Then I feel repulsive, you see? [21-year-old woman]
With time, the participants had learned to live with the
d i s e a s et os o m ee x t e n t ,b u tt h el e n g t h yc o u r s eo ft r e a t -
ment, the powerlessness and uncertainty as to when it
would end were wearing. The realisation that the disease
can remain dormant and return later in life added to the
perception of GWs as a serious condition. For the partici-
pants who had had symptom-free periods, the psycholo-
gical impact was severe when the GWs reappeared.
The social impact of having genital warts
Because of fear of stigmatisation, the participants
wanted to control who knew they had GWs. They were
worried that others might find them unclean, careless or
“of easy virtue” - the latter applied to men as well as
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important factor in shaping others’ opinions about them.
You’re afraid of being stigmatised. I remember having
heard that somebody had a venereal disease... And
that’s just what you’ll always remember about them,
even if you don’t even see them anymore. Or if you’ve
heard that about a girl that you might have thought
was quite cute, then you would think “wasn’ti th e r
who had that thing?” I nt h es a m ew a yy o ut h i n k
that’s probably how others will think about you when
you have GWs, that they think “Oh, it’s that guy
with GWs”. That’s why I have only told people I’m
very close to. [30-year-old man]
Several participants mentioned that the disease is par-
ticularly stigmatising because it is infectious and they
were concerned about people’s ignorance about the dan-
ger of infection. As a consequence, some participants
stopped doing sport or other activities that might reveal
their disease. Some women felt unattractive because
t h e yc o u l dn o ts h a v ei n t i m a t e l ya sw e l la st h e yw o u l d
have liked. Some men were concerned that others might
spot the GWs or the ulcerations caused by treatment.
The fear of stigmatisation also meant that the partici-
pants avoided informing other people that they were
attending the venereal diseases clinic for treatment.
M a n yh a dt ot a k es i g n i f i c a n tt i m ea w a yf r o mt h e i rs t u -
dies or work that was not easy to explain. Most partici-
pants had only spoken about their disease to their
closest relatives and friends.
The impact of treatment for genital warts
The participants found that different physicians managed
individual treatments and the complete course of treat-
ment for GWs in different ways. Many expressed frustra-
tion with a course of treatment that seemed to be
inconsistent and experimental. Their expectations of med-
ical solutions were at odds with the fact that there is no
‘magic bullet’ against this disease. The varying effectiveness
of treatment had a considerable impact on the patient’s
state of mind; improvement or disappearance of the GWs
was met with delight, while a recurrence or worsening of
the GWs had a correspondingly negative effect.
Several participants expressed a huge need for more
knowledge about GWs. Men in particular said they did
not like to ask for the information and would have pre-
ferred to be offered information about good hygienic
practices, how to avoid infection (for themselves and
others), the realistic prospects of the course of the dis-
ease and its possible psychological and sexual effects.
These were the kind of things that there was little
information about [in the leaflets that the patients
were handed at the clinic]. I mean, that you’re not
alone in feeling that it hurts your soul when you’ve
got this and that you can have problems with your
sex life and all such things. There isn’t one single
leaflet on dangerous diseases, such as AIDS, where it
doesn’ts a ys o m e t h i n ga b o u tt h o s ep s y c h o l o g i c a l
things. It’sl i k ei t[ G W ]i s n ’t taken that seriously,
because after all, it doesn’t do that much harm. Even
though you actually have a lot of questions like that
and there are all these psychological things that hit
you... [23-year-old man]
Discussion
The participants in this study all expressed a significant
reduction in their quality ofl i f ea sar e s u l to fh a v i n g
GWs. The unknown delay to cure, the uncertain per-
spectives of recovery as well as their inability to control
their disease all had a negative psychological effect on
them. The stigma associated with the disease affected
their self-perception and their social lives. The fact that
they had GWs was difficult to ignore because they were
constantly reminded, in particular, by the repeated treat-
ments, the disruption of their social lives and the nega-
tive effects on their sex and love life (Figure 1). These
results are supported by the findings of the few other
studies on this subject [3,14,15,32-45].
GWs was considered to be a serious disease, especially
by those participants who associated GWs with an
increased risk of developing cervical cancer, because
both are caused by human papilloma viruses (HPV)
[17]. The results of other studies have suggested that
this association can greatly influence the perception of
illness; conversely, women may regard cervical dysplasia
as stigmatising when they are informed about the sexual
transmission of HPV [4,32].
In this study, qualitative methodology was used to
obtain an in-depth insight into the experiences of
patients with GWs. The method of recruitment of the
participants may have introduced some selection bias.
Patients with a more negative experience of GWs may
be more likely to volunteer to participate in a study of
this kind. However, the patients with GWs attending the
venereal diseases clinic at Bispebjerg Hospital are con-
sidered to be representative, in terms of the severity of
their symptoms, of Danish patients with GWs in gen-
eral, in that often they attend the clinic without having
previously received treatment elsewhere or they are
referred by a general practitioner after just a few
attempts at treatment. Finally, the age of our partici-
pants may explain why, unlike those in some studies
[3,33,35], they did not raise the issues of fertility or
pregnancy. The average age of the men and women in
this study was 25.8 years and 24.4 years, respectively; in
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first child is 29.1 years [51].
We do not think that more focus-group interviews
would have produced more qualitative knowledge about
the experiences of this age group since the results are
consistent with those of previous studies. However,
further studies could investigate the effect of GWs on
the quality of life of older patients or among ethnic
minorities. Since the first publication of the results of
this study [52],a follow up study among men having sex
with men (MSM) has been published [53] and a study
of the possible long-term effects of GW is currently in
press (Ugeskrift for Læger).
Conclusions
This study contributes to our knowledge about patient
perspectives on HPV-related diseases and it suggests that
GWs affect men as much as women, psychologically,
socially and sexually. Men and women in this study
described experiences that were related to cultural per-
ceptions of venereal diseases and the respective identities
(and sexuality) of the sexes. Cultural notions of the male
identity, sexual desire and performance were at odds
with the feelings of vulnerability and lack of desire
expressed by these men. Our results suggest that there is
a considerable need for more patient information about
the disease and improved doctor-patient communication.
Men, in particular, seemed to experience psychological
barriers to seeking information and counselling. It is
clear that although GWs are not a life-threatening
disease from a medical practitioner’s point of view, they
have wide-ranging effects on the patient’s quality of life,
and these need to be taken into consideration.
The development of vaccines against HPV is a mile-
stone in the prevention of G W ,a sw e l la sc e r v i c a l
lesions and cancer. The quadrivalent HPV vaccine that
has now been added to the childhood vaccination pro-
gramme for girls in Denmark could prevent 90% of gen-
ital warts. Our results suggest that HPV vaccination
could contribute substantially to reducing the largely
unacknowledged psychological and social burden asso-
ciated with genital warts, in men as well as in women.
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